NEW YORK (GenomeWeb) — Zymo Research and CosmosID announced today that they have agreed to combine their respective technologies into a single product offering for microbiome analysis.
Under the terms of the deal, the firms will join Zymo's microbiome research portfolio — which includes tools for sample collection/preservation, nucleic acid isolation, and library preparation, as well as mock microbial community standards — with CosmosID's curated microbiome database.
As part of the alliance, CosmosID is updating its cloud-based bioinformatics platform for microbiome analysis to facilitate the use of Zymo's internal microbiome standards and to automatically assess the quality of analyzed sequence data, the companies said.
Additional terms were not disclosed.
"The partnership between CosmosID and Zymo Research is a perfect match for our customers," CosmosID CEO Manoj Dadlani said in a statement. "CosmosID is powered by the largest database of microbial genome information which enables strain level resolution of bacteria, archaea, protists, fungi, viruses and even unknown microorganisms, and Zymo Research's pipeline has proven it can consistently prepare samples that accurately reflect microbial compositions."